Roivant Sciences
ROIV
ROIV
110 hedge funds and large institutions have $3.29B invested in Roivant Sciences in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
41% more funds holding
Funds holding: 78 → 110 (+32)
4.11% more ownership
Funds ownership: 52.67% → 56.78% (+4.1%)
Holders
110
Holding in Top 10
11
Calls
$2.88M
Puts
$876K
Top Buyers
| 1 | +$209M | |
| 2 | +$42.3M | |
| 3 | +$24M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$20.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$17.6M |
Top Sellers
| 1 | -$54.7M | |
| 2 | -$34.7M | |
| 3 | -$8.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.55M |